Trials / Conditions / Hereditary Inclusion Body Myopathy (HIBM)
Hereditary Inclusion Body Myopathy (HIBM)
4 registered clinical trials studyying Hereditary Inclusion Body Myopathy (HIBM).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Efficacy Confirmation Study of NPC-09 NCT04671472 | Nobelpharma | Phase 3 |
| Completed | An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic A NCT01830972 | Ultragenyx Pharmaceutical Inc | Phase 2 |
| Completed | Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM) NCT01634750 | National Human Genome Research Institute (NHGRI) | Phase 1 |
| Completed | Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM) NCT01359319 | Ultragenyx Pharmaceutical Inc | Phase 1 |